Division of Gastroenterology, Hepatology and Nutrition
Evaluation of Infliximab Levels
Principal Investigator: Naamah Zitomersky, MD
Protocol Title: The Role of Infliximab Levels and Antibodies to Infliximab as Determinants of Clinical Remission and Loss of Response in Pediatric Inflammatory Bowel DIsease
Protocol Status: Open for Recruitment
Trial Description: The purpose of this study is to understand how infliximab and HACA antibody levels affect both remission rates and loss of response in patients with inflammatory bowel disease who have ever received this treatment.
Recruitment Information: Patients diagnosed with inflammatory bowel disease who are currently taking infliximab or who have taken infliximab in the past.
Recruitment Contact Name: Benjamin Atkinson
Recruitment Contact Phone: (856) 218-4979
Recruitment Contact Email: firstname.lastname@example.org